Societal Costs Versus Savings from Wild-Card Patent Extension Legislation to Spur Critically Needed Antibiotic Development. - Spellberg, B.; Miller, L. G.; Kuo, M. N.; Bradley, J.; Scheld, W. M.; Edwards Jr., J. E. (Infection, 2007)